[Localization of alveolitis and the effect of therapy].
D000287:Administration, Topical; D000700:Analgesics / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D001414:Bacitracin / Q000627:therapeutic use; D004338:Drug Combinations / Q000627:therapeutic use; D004368:Dry Socket / Q000188:drug therapy* / Q000473:pathology; D006801:Humans; D006847:Hydrocarbons, Iodinated / Q000627:therapeutic use*; D009355:Neomycin / Q000627:therapeutic use; D010226:Parabens / Q000627:therapeutic use; D015035:Zinc Oxide-Eugenol Cement / Q000627:therapeutic use
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D006847:Hydrocarbons, Iodinated; D010226:Parabens; D015035:Zinc Oxide-Eugenol Cement; D001414:Bacitracin; C006608:aspirin, 4-hydroxybenzoic acid propyl ester, drug combination; C003903:Nebacetin; D009355:Neomycin; C010473:iodoform; D001241:Aspirin
Lokalizacija alveolita i efekat lijecenja.